Global Small Molecule Innovator CDMO Market Growth 2025-2031

Publication ID:

LPI03258457

Publication Date:

March 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Small Molecule Innovator CDMO market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Small Molecule Innovator CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Small Molecule Innovator CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Small Molecule Innovator CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Small Molecule Innovator CDMO players cover Lonza Group, Thermo Fisher Scientific, Cambrex Corporation, CATALENT, Siegfried Holding AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪mall Molecule Innovator CDMO Industry Forecast鈥� looks at past sales and reviews total world Small Molecule Innovator CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Molecule Innovator CDMO sales for 2025 through 2031. With Small Molecule Innovator CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Innovator CDMO industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Innovator CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Small Molecule Innovator CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Small Molecule Innovator CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Innovator CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Innovator CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Innovator CDMO market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral Solid Dosage Form
Semi-solid Dosage Form
Segmentation by Application:
Pharmaceutical and Biotech Companies
Academic and Research Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lonza Group
Thermo Fisher Scientific
Cambrex Corporation
CATALENT
Siegfried Holding AG
Recipharm AB
CordenPharma International
Boehringer Ingelheim
Piramal Pharma Solutions
Covance
Key Questions Addressed in this Report
What is the 10-year outlook for the global Small Molecule Innovator CDMO market?
What factors are driving Small Molecule Innovator CDMO market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Small Molecule Innovator CDMO market opportunities vary by end market size?
How does Small Molecule Innovator CDMO break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Innovator CDMO Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Small Molecule Innovator CDMO by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Small Molecule Innovator CDMO by Country/Region, 2020, 2024 & 2031
2.2 Small Molecule Innovator CDMO Segment by Type
2.2.1 Oral Solid Dosage Form
2.2.2 Semi-solid Dosage Form
2.3 Small Molecule Innovator CDMO Sales by Type
2.3.1 Global Small Molecule Innovator CDMO Sales Market Share by Type (2020-2025)
2.3.2 Global Small Molecule Innovator CDMO Revenue and Market Share by Type (2020-2025)
2.3.3 Global Small Molecule Innovator CDMO Sale Price by Type (2020-2025)
2.4 Small Molecule Innovator CDMO Segment by Application
2.4.1 Pharmaceutical and Biotech Companies
2.4.2 Academic and Research Institutions
2.4.3 Others
2.5 Small Molecule Innovator CDMO Sales by Application
2.5.1 Global Small Molecule Innovator CDMO Sale Market Share by Application (2020-2025)
2.5.2 Global Small Molecule Innovator CDMO Revenue and Market Share by Application (2020-2025)
2.5.3 Global Small Molecule Innovator CDMO Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Small Molecule Innovator CDMO Breakdown Data by Company
3.1.1 Global Small Molecule Innovator CDMO Annual Sales by Company (2020-2025)
3.1.2 Global Small Molecule Innovator CDMO Sales Market Share by Company (2020-2025)
3.2 Global Small Molecule Innovator CDMO Annual Revenue by Company (2020-2025)
3.2.1 Global Small Molecule Innovator CDMO Revenue by Company (2020-2025)
3.2.2 Global Small Molecule Innovator CDMO Revenue Market Share by Company (2020-2025)
3.3 Global Small Molecule Innovator CDMO Sale Price by Company
3.4 Key Manufacturers Small Molecule Innovator CDMO Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Small Molecule Innovator CDMO Product Location Distribution
3.4.2 Players Small Molecule Innovator CDMO Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Small Molecule Innovator CDMO by Geographic Region
4.1 World Historic Small Molecule Innovator CDMO Market Size by Geographic Region (2020-2025)
4.1.1 Global Small Molecule Innovator CDMO Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Small Molecule Innovator CDMO Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Small Molecule Innovator CDMO Market Size by Country/Region (2020-2025)
4.2.1 Global Small Molecule Innovator CDMO Annual Sales by Country/Region (2020-2025)
4.2.2 Global Small Molecule Innovator CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Molecule Innovator CDMO Sales Growth
4.4 APAC Small Molecule Innovator CDMO Sales Growth
4.5 Europe Small Molecule Innovator CDMO Sales Growth
4.6 Middle East & Africa Small Molecule Innovator CDMO Sales Growth
5 Americas
5.1 Americas Small Molecule Innovator CDMO Sales by Country
5.1.1 Americas Small Molecule Innovator CDMO Sales by Country (2020-2025)
5.1.2 Americas Small Molecule Innovator CDMO Revenue by Country (2020-2025)
5.2 Americas Small Molecule Innovator CDMO Sales by Type (2020-2025)
5.3 Americas Small Molecule Innovator CDMO Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Innovator CDMO Sales by Region
6.1.1 APAC Small Molecule Innovator CDMO Sales by Region (2020-2025)
6.1.2 APAC Small Molecule Innovator CDMO Revenue by Region (2020-2025)
6.2 APAC Small Molecule Innovator CDMO Sales by Type (2020-2025)
6.3 APAC Small Molecule Innovator CDMO Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Small Molecule Innovator CDMO by Country
7.1.1 Europe Small Molecule Innovator CDMO Sales by Country (2020-2025)
7.1.2 Europe Small Molecule Innovator CDMO Revenue by Country (2020-2025)
7.2 Europe Small Molecule Innovator CDMO Sales by Type (2020-2025)
7.3 Europe Small Molecule Innovator CDMO Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Innovator CDMO by Country
8.1.1 Middle East & Africa Small Molecule Innovator CDMO Sales by Country (2020-2025)
8.1.2 Middle East & Africa Small Molecule Innovator CDMO Revenue by Country (2020-2025)
8.2 Middle East & Africa Small Molecule Innovator CDMO Sales by Type (2020-2025)
8.3 Middle East & Africa Small Molecule Innovator CDMO Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Small Molecule Innovator CDMO
10.3 Manufacturing Process Analysis of Small Molecule Innovator CDMO
10.4 Industry Chain Structure of Small Molecule Innovator CDMO
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Small Molecule Innovator CDMO Distributors
11.3 Small Molecule Innovator CDMO Customer
12 World Forecast Review for Small Molecule Innovator CDMO by Geographic Region
12.1 Global Small Molecule Innovator CDMO Market Size Forecast by Region
12.1.1 Global Small Molecule Innovator CDMO Forecast by Region (2026-2031)
12.1.2 Global Small Molecule Innovator CDMO Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Small Molecule Innovator CDMO Forecast by Type (2026-2031)
12.7 Global Small Molecule Innovator CDMO Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Lonza Group
13.1.1 Lonza Group Company Information
13.1.2 Lonza Group Small Molecule Innovator CDMO Product Portfolios and Specifications
13.1.3 Lonza Group Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Lonza Group Main Business Overview
13.1.5 Lonza Group Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Small Molecule Innovator CDMO Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Small Molecule Innovator CDMO Product Portfolios and Specifications
13.3.3 Cambrex Corporation Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 CATALENT
13.4.1 CATALENT Company Information
13.4.2 CATALENT Small Molecule Innovator CDMO Product Portfolios and Specifications
13.4.3 CATALENT Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CATALENT Main Business Overview
13.4.5 CATALENT Latest Developments
13.5 Siegfried Holding AG
13.5.1 Siegfried Holding AG Company Information
13.5.2 Siegfried Holding AG Small Molecule Innovator CDMO Product Portfolios and Specifications
13.5.3 Siegfried Holding AG Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Siegfried Holding AG Main Business Overview
13.5.5 Siegfried Holding AG Latest Developments
13.6 Recipharm AB
13.6.1 Recipharm AB Company Information
13.6.2 Recipharm AB Small Molecule Innovator CDMO Product Portfolios and Specifications
13.6.3 Recipharm AB Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Recipharm AB Main Business Overview
13.6.5 Recipharm AB Latest Developments
13.7 CordenPharma International
13.7.1 CordenPharma International Company Information
13.7.2 CordenPharma International Small Molecule Innovator CDMO Product Portfolios and Specifications
13.7.3 CordenPharma International Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CordenPharma International Main Business Overview
13.7.5 CordenPharma International Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Small Molecule Innovator CDMO Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 Piramal Pharma Solutions
13.9.1 Piramal Pharma Solutions Company Information
13.9.2 Piramal Pharma Solutions Small Molecule Innovator CDMO Product Portfolios and Specifications
13.9.3 Piramal Pharma Solutions Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Piramal Pharma Solutions Main Business Overview
13.9.5 Piramal Pharma Solutions Latest Developments
13.10 Covance
13.10.1 Covance Company Information
13.10.2 Covance Small Molecule Innovator CDMO Product Portfolios and Specifications
13.10.3 Covance Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Covance Main Business Overview
13.10.5 Covance Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂